Cross sectional study of factors associated to self-reported blood-borne infections among drug users

BMC Public Health

Table 4 Self-reported HCV and/or HIV positive, negative and unknown serostatus by parenteral use^a. Catalonia, 2012

	Injecting drug users	Non-injecting users	Total	p-value^b
	n = 224 (%)^c	n = 286 (%)^d	n = 510^f (%)^e	p-value^b
HCV	187 (83.48)	16 (5.59)	203 (39.80)	<0.001
HIV	68 (30.36)	8 (2.80)	76 (14.90)	<0.001
HCV + HIV	66 (29.46)	3 (1.05)	69 (13.53)	<0.001
Negative self-report of HCV and HIV	26 (11.61)	164 (57.34)	190 (37.25)
Unknown serostatus for HCV	3 (1.34)	24 (8.39)	27 (5.29)
Unknown serostatus for HIV	4 (1.79)	23 (8.04)	27 (5.29)
Unknown serostatus for HCV and HIV	2 (0.89)	54 (18.88)	56 (10.98)

HIV human immunodeficiency virus, HCV Hepatitis C virus
^aFirst three rows in the table are not mutually exclusive
^bChi square test
^cPercentages are the proportion among injecting drug users (IDUs). They do not add up to 100 because co-infected individual count in several categories
^dPercentages are the proportion among drug users who have never injected drugs. They do not add up to 100 because co-infected individual count in several categories
^ePercentages are the proportion among the total. They do not add up to 100 because co-infected individual count in several categories
^fTwo cases were not included into the analysis due to missing information related with history of drug injection. One reported negative serostatus and the other one unknown HIV serostatus

ISSN: 1471-2458